Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment

Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment

T-large granular lymphocyte leukemia (T-LGLL) is a chronic clonal proliferation of effector memory cytotoxic CD3+CD57+CD56− T cells and the current guidelines suggest immunosuppressive therapy as first-line therapy, but the treatment of refractory/relapsed patients is still challenging due to the la...

Full description

Bibliographic Details
Main Authors: Rosamilio, R., Giudice, V., Ferrara, I., Annunziata, S., Pezzullo, L., Villani, G., Baldi, C., Guariglia, R., Rocco, M., Selleri, C.
Format: Online
Language:English
Published: Università di Salerno 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120754/
id pubmed-5120754
recordtype oai_dc
spelling pubmed-51207542016-11-28 Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment Rosamilio, R. Giudice, V. Ferrara, I. Annunziata, S. Pezzullo, L. Villani, G. Baldi, C. Guariglia, R. Rocco, M. Selleri, C. Articles T-large granular lymphocyte leukemia (T-LGLL) is a chronic clonal proliferation of effector memory cytotoxic CD3+CD57+CD56− T cells and the current guidelines suggest immunosuppressive therapy as first-line therapy, but the treatment of refractory/relapsed patients is still challenging due to the lack of prospective studies. Università di Salerno 2016-11-01 /pmc/articles/PMC5120754/ /pubmed/27896231 Text en http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Rosamilio, R.
Giudice, V.
Ferrara, I.
Annunziata, S.
Pezzullo, L.
Villani, G.
Baldi, C.
Guariglia, R.
Rocco, M.
Selleri, C.
spellingShingle Rosamilio, R.
Giudice, V.
Ferrara, I.
Annunziata, S.
Pezzullo, L.
Villani, G.
Baldi, C.
Guariglia, R.
Rocco, M.
Selleri, C.
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
author_facet Rosamilio, R.
Giudice, V.
Ferrara, I.
Annunziata, S.
Pezzullo, L.
Villani, G.
Baldi, C.
Guariglia, R.
Rocco, M.
Selleri, C.
author_sort Rosamilio, R.
title Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
title_short Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
title_full Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
title_fullStr Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
title_full_unstemmed Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
title_sort prolonged complete hematologic response in relapsed/refractory t-large granular lymphocyte leukemia after bendamustine treatment
description T-large granular lymphocyte leukemia (T-LGLL) is a chronic clonal proliferation of effector memory cytotoxic CD3+CD57+CD56− T cells and the current guidelines suggest immunosuppressive therapy as first-line therapy, but the treatment of refractory/relapsed patients is still challenging due to the lack of prospective studies.
publisher Università di Salerno
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120754/
_version_ 1613738495900123136

Similar Items